Editor of Patient Care Online.
Daily Dose: Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women
Your daily dose of clinical news you may have missed.
Obesity Research Roundup for Primary Care: 5 Studies At-a-Glance from ObesityWeek® 2022
Semaglutide yields "amazing" weight loss in adolescents, phenotype-tailored lifestyle approach leads to greater weight loss vs standard methods, and more.
Daily Dose: Racial Disparities among Women Seeking Fertility Care
Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.
Survey Finds Racial Disparities among Women Seeking Fertility Care during Pandemic
Black women seeking fertility care were less likely to report getting COVID-19 vaccine and were unsatisfied with how major health care systems handled the pandemic.
Daily Dose: Alcohol Use & Stroke in Young Adults
Daily Dose: Apixaban Safest in Afib
CDC Releases Updated, Expanded Clinical Guidance on Prescribing Opioids for Pain
The 2022 guidance covers acute, subacute, and chronic pain and replaces the 2016 guidelines.
Daily Dose: Weight Loss Management in Primary Care
Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.
Daily Dose: Efficacy of Maternal RSV Vaccine
Pharmacologic Interventions for Adults with Obesity: Guideline Topline for Primary Care
The American Gastroenterological Association released its first medical guideline recommending prescription medications for weight loss in adults with obesity. A review, here.
Daily Dose: Blood Pressure Control Declined during Early Months of Pandemic
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
Tirzepatide Associated with More Weight Loss than Placebo Regardless of Obesity-related Comorbidities, New Research Finds
ObesityWeek 2022: Regardless of the number of obesity-related comorbidities, tirzepatide was associated with a greater reduction in body weight than placebo.
Early Months of COVID-19 Associated with Worsening BP Outcomes in Adults with Hypertension, New Study Finds
Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.
Daily Dose: Black Adults with Afib Less Likely to Receive Oral Anticoagulation at Hospital Discharge
Tirzepatide Led to Clinically Meaningful Improvements in Body Composition in Adults with Obesity/Overweight
ObesityWeek 2022: Tirzepatide-induced weight reduction was associated with body composition improvements in adults with obesity/overweight, found analysis of SURMOUNT-1.
Daily Dose: Low-carb Diet May Help Improve Untreated HbA1c
New AGA Guidelines Recommend Use of Antiobesity Medications for Weight Management
Adults with obesity who have an inadequate response to lifestyle interventions alone should be offered 1 of 4 suggested medications.
Daily Dose: Finerenone and Heart Failure Outcomes
Alcohol Use in America: By the Numbers
Which states have the most binge drinkers? Or the most alcohol-related deaths? A recent analysis provides answers.
Physicians Should Get Patients to Move More to Help with Cardiometabolic Health, Says One Expert
To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.
Daily Dose: Recombinant Zoster Vaccine Provides 10 Years of Protection
Daily Dose: High-dose Flu Vaccine Consistently More Effective vs Standard-dose
Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.
Daily Dose: Delay Before Start of Triple Therapy Raises Risk for COPD Exacerbations
Fluticasone Exhalation Delivery System Reduced Exacerbations, Need for Antibiotics in Patients with Chronic Sinusitis
IDWeek 2022: New data show a greater than 60% reduction in acute exacerbations and need for antibiotics in patients with CS who used fluticasone propionate nasal spray.
Daily Dose: Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Real-world Study Suggests Need for Earlier Diagnosis of Non-alcoholic Steatohepatitis
CMHC 2022: Patients with NASH are often not diagnosed until an advanced stage, and have a high burden of comorbidities, according to new study.